Table 3.
Vaccination according to destinationa (N = 1666).
|
N (%) | ||||
|---|---|---|---|---|
| Indian subcontinent N = 750 (%) | South East Asia N = 441 (%) | East Asia N = 79 (%) | Middle East N = 394 (%) | |
| Routine vaccinesb | ||||
| Hepatitis A | 73 (9.7) | 83 (18.8) | 16 (20.3) | 13 (3.3) |
| Tetanus–diphtheria | 64 (8.5) | 76 (17.2) | 17 (21.5) | 18 (4.6) |
| Hepatitis B | 9 (1.2) | 14 (3.2) | 4 (5) | 12 (3) |
| Poliomyelitis | 6 (0.8) | 2 (0.5) | 0 (0) | 8 (2) |
| Measles–Mumps–Rubella | 7 (0.9) | 6 (1.4) | 0 (0) | 2 (0.5) |
| Influenza | 3 (0.4) | 0 (0) | 0 (0) | 3 (0.8) |
| Pneumococcal | 1 (0.1) | 0 (0) | 0 (0) | 0 (0) |
| Travel vaccines | ||||
| Typhoid fever | 26 (3.5) | 31 (7) | 10 (12.6) | 11 (2.8) |
| Cholera | 4 (0.5) | 2 (0.5) | 0 (0) | 0 (0) |
| Yellow fever | 4 (0.5) | 4 (0.9) | 3 (3.8) | 13 (3.3) |
| Meningococcal (A,C, W135, Y) | 1 (0.1) | 0 (0) | 3 (3.8) | 17 (4.3) |
| Rabies | 3 (0.4) | 3 (0.7) | 1 (1.3) | 0 (0) |
| Tick-born encephalitis | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Japanese encephalitis | 1 (0.1) | 0 (0) | 0 (0) | 0 (0) |
a
The destinations of 2 travelers were unknown.
b
In accordance with the National Vaccination Program of Greece.